Risk factors for survival and the development of hepatocellular carcinoma in patients with primary biliary cirrhosis

Internal Medicine

Volumn 52, Issue 14, 2013, Pages 1553-1559

  Tomiyama, Yasuyuki ^a   Takenaka, Kazuyuki ^b   Kodama, Takahiro ^b   Kawanaka, Miwa ^a   Sasaki, Kyo ^a   Nishina, Sohji ^a   Yoshioka, Naoko ^a   Hara, Yuichi ^a   Hino, Keisuke ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b Yamaguchi Grand Medical Center   (Japan)

Author keywords

Diabetes mellitus; Liver fibrosis; Prognosis; Survival; Ursodeoxycholic acid

Indexed keywords

ALBUMIN; BILIRUBIN; HEPATITIS B CORE ANTIGEN; URSODEOXYCHOLIC ACID;

ADULT; AGE; AGED; ARTICLE; BILIARY CIRRHOSIS; CANCER STAGING; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; ECHOGRAPHY; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PORTAL HYPERTENSION; PROGNOSIS; RADIOFREQUENCY ABLATION; RISK FACTOR; SOLID TUMOR; SURVIVAL RATE;

AGED; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84880179603     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.0010     Document Type: Article

References (22)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 353: 1261-1273, 2005.
2. Selmi C, Bowlus CL, Gershwin ME, Coppel RL. Primary biliary cirrhosis. Lancet 377: 1600-1609, 2011.
3. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 335: 1570-1580, 1996.
4. Lööf L, Adami HO, Sparen P, et al. Cancer risk in primary biliary cirrhosis: a population-based study from Sweden. Hepatology 20: 101-104, 1994.
5. Jones DE, Metcalf JV, Collier JD, Bassendine MF, James OF. He-patocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology 26: 1138-1142, 1997.
6. Floreani A, Baragiotta A, Baldo V, Menegon T, Farinati F, Nacca-rato R. Hepatic and extrahepatic malignancies in primary biliary cirrhosis. Hepatology 29: 1425-1428, 1999.
7. Shibuya A, Tanaka K, Miyakawa H, et al. Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis. Hepa-tology 35: 1172-1178, 2002.
8. Caballeria L, Pares A, Castells A, Gines A, Bru C, Rodes J. Hepa-tocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. Am J Gastroenterol 96: 1160-1163, 2001.
9. Cavazza A, Caballeria L, Floreani A, et al. Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: comparative analysis from two centers. Hepatology 50: 1162-1168, 2009.
10. Harada K, Hirohara J, Ueno Y, et al. Incidence of and risk factors for hepatocellular carcinoma in primary biliary cirrhosis: National data from Japan. Hepatology (in press).
11. Suzuki A, Lymp J, Donlinger J, Mendes F, Angulo P, Lindor K. Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol 5: 259-264, 2007.
12. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126: 460-468, 2004.
13. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638, 2003.
14. Scheuer P. Primary biliary cirrhosis. Proc R Soc Med 60: 1257-1260, 1967.
15. Nijhawan PK, Therneau TM, Dickson ER, Boynton J, Lindor KD. Incidence of cancer in primary biliary cirrhosis: the Mayo experience. Hepatology 29: 1396-1398, 1999.
16. Howel D, Metcalf JV, Gray J, Newman WL, Jones DE, James OF. Cancer risk in primary biliary cirrhosis: a study in northern England. Gut 45: 756-760, 1999.
17. Floreani A, Caroli D, Variola A, et al. A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver Int 31: 361-368, 2011.
18. Kuiper EM, Hansen BE, de Vries RA, et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology 136: 1281-1287, 2009.
19. Corpechot C, Chazouilleres O, Poupon R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol 55: 1361-1367, 2011.
20. N'Kontchou G, Paries J, Htar MT, et al. Risk factors for hepato-cellular carcinoma in patients with alcoholic or viral C cirrhosis. Clin Gastroenterol Hepatol 4: 1062-1068, 2006.
21. El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol 96: 2462-2467, 2001.
22. Hines IN, Hartwell HJ, Feng Y, et al. Insulin resistance and metabolic hepatocarcinogenesis with parent-of-origin effects in AxB mice. Am J Pathol 179: 2855-2865, 2011.